BRITT WARNER: Open Payments
NPI 1588842165 · LONGMONT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 14 payments from 10 companies in 2025. Trend: 2023 $23 · 2024 $0 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $92 |
| Janssen Biotech, Inc. | 2 | $34 |
| Genmab U.S., Inc. | 1 | $34 |
| SOBI, INC | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $22 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $22 |
| Iovance Biotherapeutics, Inc. | 1 | $17 |
Products named: Vyloy, Tivdak, Vonjo, Nubeqa, IMFINZI, DANZITEN, MYRISK, ENJAYMO.
Industry payments across CO — which companies pay providers there.
